Prelude Therapeutics PRLD
NASDAQ PRLD
$3.68 +0.15 (+4.25%)
As of: Oct 21, 2026 · 2:36 PM EDT

Prelude Therapeutics (PRLD) Asset Utilization Ratio (2025 - 2026)

Updated

Prelude Therapeutics' Asset Utilization Ratio was 0.15 in Q2 2026, up 165.6% from 0.05 a year earlier and up 13.3% from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at Prelude Therapeutics came in at 0.08, up 148.1% from FY2024.

  • In earlier years, Asset Utilization Ratio was 0.03 in FY2024.
  • Per Business Quant data, PRLD's Asset Utilization Ratio in the three quarters before Q2 2026 was 0.13 (Q1 2026), 0.10 (Q4 2025) and 0.10 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,135.99 Bn 1,104.58 Bn 19.71 Bn 0.62
2 Johnson & Johnson 616.90 Bn 535.42 Bn 17.26 Bn 0.49
3 AbbVie 501.56 Bn 474.68 Bn 12.70 Bn 0.47
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 0.52
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 0.46
6 Astrazeneca 261.45 Bn 235.13 Bn 12.86 Bn 0.51
7 Amgen 236.48 Bn 191.88 Bn 7.24 Bn 0.40
8 Gilead Sciences 190.56 Bn 164.76 Bn 6.22 Bn 0.58
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 0.31
10 Prelude Therapeutics 362.07 Mn -235.23 Mn - 0.15
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.15
Mar 31, 2026 0.13
Dec 31, 2025 0.10
Sep 30, 2025 0.10
Jun 30, 2025 0.05
API Access

Prelude Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=PRLD&period=max&api_key=YOUR_API_KEY